Does EMPAGLIFLOZIN Cause Pulmonary hypertension? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Pulmonary hypertension have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.1% of all adverse event reports for EMPAGLIFLOZIN.
26
Reports of Pulmonary hypertension with EMPAGLIFLOZIN
0.1%
of all EMPAGLIFLOZIN reports
2
Deaths
12
Hospitalizations
How Dangerous Is Pulmonary hypertension From EMPAGLIFLOZIN?
Of the 26 reports, 2 (7.7%) resulted in death, 12 (46.2%) required hospitalization, and 1 (3.8%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does EMPAGLIFLOZIN Cause?
Diabetic ketoacidosis (3,644)
Fungal infection (1,941)
Blood glucose increased (1,797)
Euglycaemic diabetic ketoacidosis (1,769)
Weight decreased (1,661)
Urinary tract infection (1,439)
Ketoacidosis (1,411)
Dizziness (1,372)
Nausea (1,333)
Vomiting (1,201)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
Which EMPAGLIFLOZIN Alternatives Have Lower Pulmonary hypertension Risk?
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\LINAGLIPTIN\METFORMIN
EMPAGLIFLOZIN vs EMPAGLIFLOZIN\METFORMIN
EMPAGLIFLOZIN vs EMSAM
EMPAGLIFLOZIN vs EMTRICITABINE